Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia Blood Adv
Critical review of clinical data and expert-based recommendations for the use of bosutinib in the treatment of chronic myeloid leukemia Front Oncol
Low dose lenalidomide versus placebo in non-transfusion dependent patients with low risk, del(5q) myelodysplastic syndromes (SintraREV): a randomised, double-blind, phase 3 trial Lancet Haematol
Butyrate and propionate are microbial danger signals that activate the NLRP3 inflammasome in human macrophages upon TLR stimulation Cell Rep
Immunoparesis recovery in newly diagnosed transplant ineligible multiple myeloma patients, an independent prognostic factor that complements minimal residual disease ANN HEMATOL
The effects of ENDOG on lipid metabolism may be tissue-dependent and may not require its translocation from mitochondria Nat Commun
CLL crosstalk with naïve T cells enhances the differentiation of IL-22-producing T cells and CLL -cell survival Leukemia
Integrative ensemble modelling of cetuximab sensitivity in colorectal cancer patient-derived xenografts Nat Commun